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General Methods: All reactions were carried out under argon. For column chromatography, silica 
gel (KANTO KAGAKU N-60) was employed. Exact mass spectra were recorded on Waters 
MICROMASS® LCT PREMIERTM or Bruker Esquire200T. NMR spectra were recorded using JEOL 
GSX400 spectrometer at 400 MHz frequency for 1H and 100 MHz frequency for 13C in CDCl3. 
Chemical shifts are calibrated to the solvent signal. For HPLC separations, a Cosmosil 5C18-AR-II 
analytical column (Nacalai Tesque, 4.6×250 mm, flow rate 1 mL/min) or a 5C18-AR-II 
semi-preparative column (Nacalai Tesque, 10×250 mm, flow rate 2.5 mL/min) was employed, and 
eluting products were detected by UV at 220 nm. A solvent system consisting of 0.1% TFA in H2O 
(v/v, soluvent A) and 0.1% TFA in MeCN (v/v, solvent B) was used for HPLC elution. Fluorescent 
spectra were recorded on Hitachi F-4500. Oligodeoxynucleotides were purchased form Nippon EGT 
Co., Ltd. 
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Preparation of Thiol-Responsive Amino Acid 
 
Reagents and conditions. (i) p-nitrobenzenesulfonyl chloride (pNsCl), K2CO3, acetone, reflux, quant.; (ii) AcOH, 
H2O, THF, quant.; (iii) PCC, CH2Cl2, 91%; (iv) NaClO2, NaH2PO4, tert-BuOH, H2O, acetone, 
2-methyl-2-butene; (v) HCl, AcOEt; (vi) FmocOSu, Na2CO3, H2O, MeCN, 70% (3 steps); (vii) Fmoc SPPS; (viii) 
TFA/Triethylsilane/H2O=95/2.5/2.5. 
 
2-tert-Butoxycarbonylamino-3,3-dimethyl-3-[2,4-dimethyl-6-(nitrobenzene-4-sulfonyloxy)- 
phenyl] propanol tert-butyldimethylsilyl ether (4). 
To a stirred solution of phenol 3 (25.0 mg, 57.1 µmol) in acetone were added K2CO3 (81.0 mg, 818 
µmol) and p-nitrobenzenesulfonyl chloride (33.8 mg, 90% purity, 137 µmol), and the resulting 
suspension was refluxed for 5.5 h. The resulting mixture was quenched by the addition of water and 
was extracted with AcOEt. The combined organic layer was washed with brine, dried over MgSO4 
and concentrated in vacuo. The crude product was purified by column chromatography (SiO2, 
hexane/AcOEt=10/1) and 35.6 mg of sulfonate 2 (57.1 µmol, quant) was obtained as a colorless oil: 
1H NMR (CDCl3, 400 MHz) δ=-0.07 (6H, s), 0.83 (9H, s), 1.31 (3H, s), 1.37 (9H, s), 1.44 (3H, s), 
2.22 (3H, s), 2.62 (3H, s), 3.38 (1H, dd, J=11.3 and 4.7 Hz), 3.43 (1H, dd, J=11.3 and 4.7 Hz), 4.27 
(1H, dt, J=9.8 and 4.7 Hz), 4.73 (1H, d, J=9.8 Hz), 6.89 (1H, s), 6.94 (1H, s), 8.24 (2H, d, J=8.7 Hz), 
8.42 (2H, d, J=8.7 Hz); 13C NMR (CDCl3, 100 MHz) δ=-5.5 (CH3), -5.4 (CH3), 18.2 (C), 20.3 (CH3), 
25.7 (CH3), 25.8 (CH3×3), 26.7 (CH3), 28.3 (CH3×3), 28.5 (CH3), 44.3 (CH3), 56.5 (CH), 63.3 (CH2), 
78.8 (C), 120.6 (CH), 124.3 (CH×2), 129.8 (CH×2), 133.4 (CH), 133.9 (C), 136.7 (C), 140.0 (C), 
142. (C)4, 149.2 (C), 150.8 (C), 155.9 (C); HRMS (ESI-TOF) calc. for C30H47N2O8SSi ([M+H]+): 
623.2822, found; 623.2827. 
 
2-tert-Butoxycarbonylamino-3,3-dimethyl-3-[2,4-dimethyl-6-(nitrobenzene-4-sulfonyloxy)- 
phenyl]propanol (5). 
Glacial acetic acid (450 µL) and water (153 µL) were added to a solution of silyl ether 4 (37.0 mg, 
59.4 µmol) in THF (153 µL). The reaction mixture was stirred overnight. After extraction with 
AcOEt, the organic phase was washed with saturated aqueous solution of NaHCO3 and brine, dried 
over Na2SO4 and concentrated in vacuo. The crude product was purified by column chromatography 
(SiO2, hexane/AcOEt=4/1 then 1/1) and 30.2 mg of alcohol 5 (59.4 µmol, quant.) was obtained as a 
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pale yellow oil: 1H NMR (CDCl3, 400 MHz) δ=1.25 (3H, s), 1.39 (9H, s), 1.44 (3H, s), 2.19 (3H, s), 
2.62 (3H, s), 3.44 (1H, dd, J=11.6 and 8.1 Hz), 3.52 (1H, dd, J=11.6 and 2.6 Hz), 4.42 (1H, m), 4.78 
(1H, d, J=9.3 Hz), 6.81 (1H, s), 6.91 (1H, s), 8.23 (2H, d, J=8.2 Hz), 8.44 (2H, d, J=8.2 Hz); 13C 
NMR (CDCl3, 100 MHz) δ=20.3 (CH3), 25.7 (CH3), 26.6 (CH3), 28.1 (CH3), 28.3 (CH3×3), 43.7 (C), 
58.0 (CH), 63.5 (CH2), 79.5 (C), 120.9 (CH), 124.4 (CH×2), 129.7 (CH×2), 133.5 (C), 133.6 (CH), 
137.0 (C), 139.8 (C), 142.3 (C), 149.0 (C), 150.9 (C), 156.6 (C); HRMS (ESI-TOF) calc. for 
C24H33N2O8S ([M+H]+): 509.1958, found; 509.1950. 
 
2-tert-Butoxycarbonylamino-3,3-dimethyl-3-[2,4-dimethyl-6-(nitrobenzene-4-sulfonyloxy)- 
phenyl] propanal (6). 
To a stirred solution of alcohol 5 (30.2 mg, 59.4 µmol) in dichloromethane (887 µL) was added PCC 
(131 mg, 475 µmol), and the resulting suspension was stirred overnight. To the reaction mixture was 
added the Celite and the obtained mixture was filtrated through the Celite pad. The resulting solution 
was concentrated in vacuo. The crude product was purified by column chromatography (SiO2, 
hexane/AcOEt=1/0 then 4/1) and 27.3 mg of aldehyde 6 (53.9 µmol, 91%) was obtained as a 
colorless oil: 1H NMR (CDCl3, 400 MHz) δ=1.31 (3H, s), 1.39 (9H, s), 1.42 (3H, s), 2.24 (3H, s), 
2.69 (3H, s), 5.09 (1H, d, J=8.3 Hz), 5.22 (1H, d, J=8.3 Hz), 6.95 (1H, s), 6.98 (1H, s), 8.21 (2H, d, 
J=8.7 Hz), 8.43 (2H, d, J=8.7 Hz), 9.27 (1H, s); 13C NMR (CDCl3, 100 MHz) δ=20.4 (CH3), 25.4 
(CH3), 26.5 (CH3), 27.7 (CH3), 28.2 (CH3×3), 43.2 (C), 65.2 (CH), 79.9 (C), 121.2 (CH), 124.4 
(CH×2), 129.8 (CH×2), 131.5 (C), 133.8 (CH), 137.8 (C), 139.7 (C), 142.1 (C), 148.8 (C), 150.9 (C), 
155.9 (C), 200.1 (C); HRMS (ESI-TOF) calc. for C24H31N2O8S ([M+H]+): 507.1801, found; 
507.1801. 
 
3,3-Dimethyl-3-[2,4-dimethyl-6-(nitrobenzene-4-sulfonyloxy)phenyl]-2-(9-fluorenylmethyl- 
carbonylamino)propionic acid (7). 
To a solution of aldehyde 6 (27.3 mg, 53.9 µmol) in acetone/tert-BuOH/H2O (55/35/10 v/v/v, 1.17 
mL) were added 2-methyl-2-butene (42.6 µL, 377 µmol), NaH2PO4 (10.3 mg, 85.8 µmol) and 
NaClO2 (29.3 mg, 324 µmol), and the resulting mixture was stirred overnight. The reaction mixture 
was poured into saturated aqueous solution of NH4Cl and it was extracted with diethyl ether. The 
organic phase was dried over Na2SO4 and concentrated in vacuo. Hydrogen chloride in AcOEt (4 M, 
432 µL) was added to the crude product, and the resulting mixture was stirred for 1 h. After 
concentration in vacuo, the obtained residue was dissolved in acetonitrile/10% w/v aqueous solution 
of Na2CO3 (1/1, 486 µL). To the resulting solution was added FmocOSu (19.1 mg, 56.6 µmol), and 
the reaction mixture was stirred overnight. After acidification with 5% w/v aqueous solution of 
KHSO4, the obtained mixture was extracted with diethyl ether. The organic phase was washed with 
brine and concentrated in vacuo. The obtained crude product was purified by a preparative TLC 
 S4 
(SiO2, chloroform/MeOH=10/1) and 24.2 mg of Fmoc derivative 7 (37.5 µmol, 70% (3 steps)) was 
obtained as a pale yellow amorphousness: 1H NMR (CDCl3, 400 MHz) δ=1.52 (3H, s), 1.55 (3H, s), 
2.15 (3H, s), 2.63 (3H, s), 4.15 (1H, t, J=7.2 Hz), 4.27 (1H, dd, J=10.4 and 7.2 Hz), 4.35 (1H, dd, 
J=10.4 and 7.2 Hz), 4.44 (1H, br s), 5.19 (1H, d, J=9.0 Hz), 5.70 (1H, d, J=9.0 Hz), 6.70 (1H, s), 
6.90 (1H, s), 7.22-7.30 (2H, m), 7.38 (2H, t, J=7.4 Hz), 7.49 (1H, d, J=7.4 Hz), 7.55 (1H, d, J=7.4 
Hz), 7.75 (2H, d, J=7.4 Hz), 8.19 (2H, d, J=8.5 Hz), 8.39 (2H, d, J=8.5 Hz); 13C NMR (CDCl3, 100 
MHz) δ=20.3 (CH3), 25.0 (CH3), 27.5 (CH3), 27.9 (CH3), 43.4 (C), 47.1 (CH), 59.6 (CH), 67.1 
(CH2), 119.9 (CH), 121.0 (CH), 121.0 (CH), 124.4 (CH×2), 125.0 (CH×2), 126.9 (CH×2), 127.6 
(CH×2), 129.6 (CH×2), 132.1 (C), 133.6 (CH), 137.3 (C), 139.9 (C), 141.2 (C), 142.2 (C×2), 143.6 
(C), 143.6 (C), 148.7 (C), 150.9 (C), 156.1 (C), 175.4 (C); HRMS (ESI-TOF) calc. for C34H33N2O9S 
([M+H]+): 645.1907, found; 645.1919. 
 
Preparation and Processing Reaction of Thiol Responsive Model Peptide 
 
Preparation of thiol-responsive model peptide 2 
Peptide 2 was synthesized by Fmoc SPPS according to a previous report.S1 Analytical HPLC 
condition: linear gradient of solvent B in solvent A, 10 to 80% over 30 min. Retention time=22.6 and 
23.2 min, respectively for each diastereomer of peptide 2. Semi-preparative HPLC condition: linear 
gradient of solvent B in solvent A, 30 to 70% over 30 min. MS (ESI-IT) calc. for C68H88N13O17S 
([M+H]+): 1390.6, found; 1390.7 and 1390.7. 
 
Processing reaction of model peptide 2 
Typical procedure: A stock solution of peptide 2 (0.5% w/v in MeCN/H2O=1/1, 4.2 µL; final 
concentration=0.02% w/v) was added to a mixture of phosphate buffer (pH 9.0, 100 mM, 21.0 µL; 
final concentration=20 mM), MeCN (31.5 µL; final concentration=30% v/v) and H2O (38.9 µL). To 
reaction mixture was added an aqueous solution of sodium 2-mercaptoethanesulfonate (1% 
w/v, 10.5 µL; final concentration=0.1% w/v) and the obtained solution was incubated at 
37 °C. Reaction progress was monitored by analytical HPLC and products were 
characterized by ESI-MS. Spectral data were identical with those reported previously.S1 
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Analytical HPLC condition: linear gradient of solvent B in solvent A, 10 to 80% over 30 min. 
Retention time=10.9, 21.3 and 21.6 min, respectively for 9, 8 and 8’ (an epimer of 8 at the carbon 
designated by an asterisk). Yields were calculated by following equation. 
 
yield (%)=100×[A(8)+A (8’)+A(9)]/[A(2)+A(8)+A(8’)+A(9)] 
 A(n): peak area of compound n in HPLC chart. 
 
 
Preparation and Processing Reaction of Thiol-Responsive PNA 
Preparation of thiol-responsive PNA 12 
 
PNA 12 was synthesized by using Fmoc SPPS. Reagents and conditions are summarized in Table S1.  
Fmoc-t-OH was synthesized according to a literature.S2 Analytical HPLC condition: linear gradient 
of solvent B in solvent A, 1 to 50% over 30 min. Retention time=22.0 min. MS (ESI-IT) calc. for 
C115H152N38O40S ([M+2H]2+): 1369.1, found; 1369.1. 
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Table S1 
residue No. reagents (eq.)a reaction time 
1 Fmoc-t-OH (5), PyBOP (5), NEM (10) 1 h 
2 Fmoc-t-OH (5), PyBOP (5), NEM (10) 1 h 
3 Fmoc-t-OH (5), PyBOP (5), NEM (10) 1 h 
4 Fmoc-t-OH (5), PyBOP (5), NEM (10) 1 h 
5 7 (2), PyBOP (2), NEM (4) overnight 
6 Fmoc-Gly-OH (5), PyBOP (5), NEM (10) 1 h 
7 Fmoc-t-OH (4), HCTU (3.8), DIEA (4) 2 h 
8 Fmoc-t-OH (4), HCTU (3.8), DIEA (4) 2 h 
9 Fmoc-t-OH (4), HATU (3.8), DIEA (4) 2 h 
10 Fmoc-t-OH (4), HATU (3.8), DIEA (4) 12 h (twice) 
11 Fmoc-Lys(Boc)-OH (4), HATU (3.8), DIEA (4) 12 h (twice) 
(a) DMF/DMSO=3/1 was used as a solvent. 
 
HATU: 2-(1H-7-azabenzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate 
HCTU: 5-chloro2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate 
NEM: N-ethylmorpholine 
PyBOP: (1H-1,2,3-benzotriazolyloxy)tris(pyrrolidino)phosphonium hexafuluorophosphate 
 
Processing reaction of PNA 12 
A stock solution of PNA 12 (0.5% w/v in H2O, 5.6 µL; final concentration=0.02% w/v) was added to 
a mixture of phosphate buffer (pH 9.0, 100 mM, 28.0 µL; final concentration=20 mM) and H2O (105 
µL). To reaction mixture was added an aqueous solution of sodium 2-mercaptoethanesulfonate 
11 (10% w/v, 1.4 µL; final concentration=0.1% w/v) and the obtained solution was 
incubated at 37 °C for 24 h, which was followed by the second addition of thiol 11 (10% 
w/v, 1.4 µL; final concentration=0.1% w/v), and the reaction mixture was incubated at 37 °C 
for additional 24 h. Reaction progress was monitored by analytical HPLC and products 
were characterized by ESI-MS. Analytical HPLC condition: linear gradient of solvent B in 
solvent A, 1 to 50% over 30 min. Retention time=10.8 and 20.7 min, respectively for 14 and 13. MS 
(ESI-IT) calc. for 14: C44H60N17O16 ([M+H]+): 1082.4, found; 1082.4. 13: C65H89N20O20 ([M+H]+): 
1469.7, found; 1469.5. 
 
Melting Temperature Experiments 
The melting temperature experiments were performed according to the literature with slight 
modification.S3 Melting curves were recorded by a fluorescence spectrometer (λex=525 nm, 
λem=600 nm) after addition of an ethidium bromide (5.0 µM). Conditions: 4.0 µM concentration for 
each strand, 10 mM phosphate buffer (pH 9.0), 100 mM NaCl. thiol +: The sample was first treated 
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with thiol 11 (0.1% w/v) at 37 °C for 24 h, and then it was treated with additional thiol 11 (0.1% w/v) 
at 37 °C for 24 h. 
 
Supplemental Figures  
0
10
20
30
40
50
60
70
80
90
100
0 24 48 72
Reaction time/h
Y
ie
ld
 o
f 
p
ro
c
e
s
s
in
g
 p
ro
d
u
c
ts
/
%
 
Figure S1. Yield of processing products relative to reaction time. 
Reaction conditions: Peptide 2 (0.02% w/v and thiol 11 (0.1% w/v) 
in 30% v/v MeCN/phosphate buffer (pH 9.0, 20 mM) were 
incubated at 37 °C. 
 
 
 
 
Figure S2. HPLC profiles (a) before treatment with thiol 11 
and (b) after 24 h incubation with 0.1% w/v thiol 11 at 37 °C 
under Ar, followed by subsequent incubation with additional 
thiol 0.1% w/v thiol 11 at 37 °C for 24 h. Peptides were 
detected by UV absorbance at 220 nm. Asterisked peak is not 
a peptidic compound. 
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